Research
Showing 385–400 of 510 results
-
PhospholipidsPhospholipids 0.25 mM
-
PhospholipidsPhospholipid-TGT Emulsion 0,5 mM
-
Congenital deficient plasmas (Kits)Deficient Human Plasma in Native VWF (VWD Type 1)
-
Congenital deficient plasmas (Kits)Deficient Human Plasma in Native VWF (VWD Type 2A)
-
Congenital deficient plasmas (Kits)Deficient Human Plasma in Native VWF (VWD Type 2B)
-
Congenital deficient plasmas (Kits)Deficient Human Plasma in Native VWF (VWD Type 3)
-
Genetic disordersPlasma from heterozygous prothrombin gene mutation G20210A
-
Plasmas with anticoagulant drugs
Plasma with direct thrombin inhibitor (Lepirudin)
-
Genetic disorders
Plasma with Factor V Leiden (heterozygous mutation)
-
Genetic disorders
Plasma with Factor V Leiden (homozygous mutation)
-
High Factor plasmas
Plasma with high level of C protein: > 150 %
-
Fibrinogen plasmas
Plasma with high level of fibrinogen: 6 – 10 g/L
-
High Factor plasmas
Plasma with high level of S protein: > 150 %
-
Plasmas with anticoagulant drugs
Plasma with NOAC – Fondaparinux (Arixtra®)
-
Fibrinogen plasmas
Plasma with ultra high level of fibrinogen: >10 g/L
-
Immunodepleted deficient plasmasPlasminogen Immunodepleted Deficient Human Plasma